Global Human Insulin Market (Product Type, Brand and Geography) 2013-2020
Big Market Research, Global Human Insulin Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, 2013 – 2020. Browse full report @ http://www.bigmarketresearch.com/human-insulin-market
Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is expected to grow at healthy CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth analysis of the global human insulin market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities.
Big Market Research, Global Human Insulin Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, 2013 – 2020. Browse full report @ http://www.bigmarketresearch.com/human-insulin-market
Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is expected to grow at healthy CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth analysis of the global human insulin market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities.
Report Description Global Human Insulin Market by Types The global human insulin market is segmented by product type into Traditional and Modern Human Insulin. Traditional Human Insulin is segmented as Premixed, Intermediate Acting and Short Acting Human Insulin, whereas Modern Human Insulin includes Premixed, Long Acting and Rapid Acting types. Long acting modern insulin and premixed modern insulin are the fastest growing categories of this segment. Global Human Insulin Market by Brands According to the brands available into the market, the global human insulin market is classified as traditional and modern human insulin brands. Traditional brands include Humulin, Actrapid and Insuman, whereas, modern brands include Humalog, Novomix, Novorapid, Lantus, Levemir and Apidra. Over the past few years, biosimilars has gained popularity in comparison to branded drugs. Basalog, Wosulin and Glaritus are the biosimilars available in Asia-Pacific region. Request for Table of Contents @ http://www.bigmarketresearch.com/human-insulin-market
Report Description Global Human Insulin Market by Geography Geographically, global human insulin market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global human insulin market owing to high prevalence of diabetes and technological advances in effective insulin delivery. Asia-Pacific and LAMEA are the fastest growing geographic segments due to high diabetes incidences, government support and improving healthcare conditions. Competitive Landscape Eli Lilly, GlaxoSmithCline, Biocon, Sanofi Aventis, Julphar, Novo Nordisk, SemBioSys, and Wockhardt are some of the key players of global human insulin market. Manufacturers are focusing to develop the advanced techniques of insulin delivery to gain the competitive advantage. Development of biosimilars is a booming trend in global human insulin market and Wockhardt and Biocon have launched their biosimilars products in Asia-Pacific region.
- Page 1 and 2: Global Human Insulin Market (Produc
- Page 3: Report Description The growth of gl
- Page 7 and 8: Report Description KEY BENEFITS Thi
- Page 9 and 10: Report Description MARKET BY BRAND
Report Description<br />
<strong>Global</strong> <strong>Human</strong> <strong>Insulin</strong> <strong>Market</strong> by <strong>Geography</strong><br />
Geographically, global human insulin market is segmented into North America, Europe,<br />
Asia-Pacific <strong>and</strong> LAMEA. North America dominates the global human insulin market<br />
owing to high prevalence of diabetes <strong>and</strong> technological advances in effective insulin<br />
delivery. Asia-Pacific <strong>and</strong> LAMEA are the fastest growing geographic segments due to high<br />
diabetes incidences, government support <strong>and</strong> improving healthcare conditions.<br />
Competitive L<strong>and</strong>scape<br />
Eli Lilly, GlaxoSmithCline, Biocon, Sanofi Aventis, Julphar, Novo Nordisk, SemBioSys, <strong>and</strong><br />
Wockhardt are some of the key players of global human insulin market. Manufacturers<br />
are focusing to develop the advanced techniques of insulin delivery to gain the<br />
competitive advantage. Development of biosimilars is a booming trend in global human<br />
insulin market <strong>and</strong> Wockhardt <strong>and</strong> Biocon have launched their biosimilars products in<br />
Asia-Pacific region.
Change language